Literature DB >> 24032666

Molecular features of neural stem cells enable their enrichment using pharmacological inhibitors of survival-promoting kinases.

Christine Y Brazel1, Abdulaziz A Alaythan, Ryan J Felling, Frances Calderon, Steven W Levison.   

Abstract

Isolating a pure population of neural stem cells (NSCs) has been difficult since no exclusive surface markers have been identified for panning or FACS purification. Moreover, additional refinements for maintaining NSCs in culture are required, since NSCs generate a variety of neural precursors (NPs) as they proliferate. Here, we demonstrate that post-natal rat NPs express low levels of pro-apoptotic molecules and resist phosphatidylinositol 3'OH kinase and extracellular regulated kinase 1/2 inhibition as compared to late oligodendrocyte progenitors. Furthermore, maintaining subventricular zone precursors in LY294002 and PD98059, inhibitors of PI3K and ERK1/2 signaling, eliminated lineage-restricted precursors as revealed by enrichment for Nestin(+)/SOX-2(+) cells. The cells that survived formed neurospheres and 89% of these neurospheres were tripotential, generating neurons, astrocytes, and oligodendrocytes. Without this enrichment step, less than 50% of the NPs were Nestin(+)/SOX-2(+) and 42% of the neurospheres were tripotential. In addition, neurospheres enriched using this procedure produced 3-times more secondary neurospheres, supporting the conclusion that this procedure enriches for NSCs. A number of genes that enhance survival were more highly expressed in neurospheres compared to late oligodendrocyte progenitors. Altogether, these studies demonstrate that primitive neural precursors can be enriched using a relatively simple and inexpensive means that will facilitate cell replacement strategies using stem cells as well as other studies whose goal is to reveal the fundamental properties of primitive neural precursors.
© 2013 International Society for Neurochemistry.

Entities:  

Keywords:  apoptosis; brain; caspase 3; cell death; differentiation; subventricular zone

Mesh:

Substances:

Year:  2013        PMID: 24032666      PMCID: PMC3946960          DOI: 10.1111/jnc.12447

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  61 in total

1.  cAMP stimulates protein kinase B in a Wortmannin-insensitive manner.

Authors:  C L Sable; N Filippa; B Hemmings; E Van Obberghen
Journal:  FEBS Lett       Date:  1997-06-09       Impact factor: 4.124

2.  Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

Authors:  R J Crowder; R S Freeman
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

3.  An improved method for propagating oligodendrocyte progenitors in vitro.

Authors:  G M Young; S W Levison
Journal:  J Neurosci Methods       Date:  1997-12-01       Impact factor: 2.390

4.  Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27.

Authors:  H Konishi; H Matsuzaki; M Tanaka; Y Takemura; S Kuroda; Y Ono; U Kikkawa
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

Review 5.  Double identity for proteins of the Bcl-2 family.

Authors:  J C Reed
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

6.  p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation.

Authors:  S P Linke; K C Clarkin; G M Wahl
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

7.  Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury.

Authors:  S D D'Souza; K A Alinauskas; J P Antel
Journal:  J Neurosci Res       Date:  1996-02-01       Impact factor: 4.164

8.  Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms.

Authors:  S K Moule; G I Welsh; N J Edgell; E J Foulstone; C G Proud; R M Denton
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

9.  Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes.

Authors:  A Brogi; M Strazza; M Melli; E Costantino-Ceccarini
Journal:  J Cell Biochem       Date:  1997-09-15       Impact factor: 4.429

10.  Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis.

Authors:  B Scurlock; G Dawson
Journal:  J Neurosci Res       Date:  1999-02-15       Impact factor: 4.164

View more
  5 in total

1.  Effects of NOTCH1 signaling inhibitor γ-secretase inhibitor II on growth of cancer stem cells.

Authors:  Xiaodong Ding; Changqing Ding; Fei Wang; Wenshuai Deng; Mingming Yu; Qinghai Meng; Peng Sun
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

2.  Mechanisms of mouse neural precursor expansion after neonatal hypoxia-ischemia.

Authors:  Krista D Buono; Matthew T Goodus; Mariano Guardia Clausi; Yuhui Jiang; Dean Loporchio; Steven W Levison
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

3.  Cardiotrophin-1 stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through PI3K/Akt-dependent signaling pathways.

Authors:  Longying Peng; Xiaomei Shu; Changhui Lang; Xiaohua Yu
Journal:  Cytotechnology       Date:  2017-06-10       Impact factor: 2.058

4.  Ionizing Radiation Perturbs Cell Cycle Progression of Neural Precursors in the Subventricular Zone Without Affecting Their Long-Term Self-Renewal.

Authors:  Hongxin Chen; Matthew T Goodus; Sonia M de Toledo; Edouard I Azzam; Steven W Levison; Nizar Souayah
Journal:  ASN Neuro       Date:  2015-06-08       Impact factor: 4.146

Review 5.  Improvements in biomaterial matrices for neural precursor cell transplantation.

Authors:  Nolan B Skop; Frances Calderon; Cheul H Cho; Chirag D Gandhi; Steven W Levison
Journal:  Mol Cell Ther       Date:  2014-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.